Publications
Print PDF
Federal Circuit Delays Sandoz Biosimilar
July 21, 2015
John Aquino
Bloomberg BNA Pharmaceutical Law & Industry Report

Axinn Counsel Stacie Ropka was quoted in the Bloomberg BNA Pharmaceutical Law & Industry Report article, "Federal Circuit Delays Sandoz Biosimilar Until Sept. 2."

Click here to read the article. A subscription is required.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.